Filing Flows › Expensify (EXFY) › Guidance & outlook
Expensify (EXFY) guidance and outlook
Expensify (EXFY) raised its guidance on Nov 5, 2026: Free cash flow $13.5M–$15.5M for the year ending Dec 31, 2026. Expensify's 10-Q filed Nov 5, 2026 makes 4 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Free cash flow | the year ending Dec 31, 2026 | $13.5M–$15.5M | raised |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- We capitalize certain software development costs that are attributable to developing or adding significant functionality to our internal-use software during the application development stage of the projects.
- We expect to continue to make investments in and expand our product and service offerings to enhance our customers’ experience and satisfaction and to attract new customers.
- We will continue to capitalize and amortize R&D costs over 15 years for R&D performed outside of the U.S.
- Under the 2025 Share Repurchase Program, we may repurchase shares from time to time through open market purchases, in privately negotiated transactions or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 of the Exchange Act, in accordance with applicable securities laws and other restrictions.
Expensify's latest quarter
Expensify, Q3 2026: revenue $33.0M (-6% year over year), operating margin -8.1%, net loss $3.3M, operating cash flow $4.0M. The chart follows the revenue to costs, profit and cash.
Questions
Did Expensify raise or lower its guidance?
Expensify (EXFY) raised its guidance on Nov 5, 2026: Free cash flow $13.5M–$15.5M for the year ending Dec 31, 2026.
What does Expensify expect?
We capitalize certain software development costs that are attributable to developing or adding significant functionality to our internal-use software during the application development stage of the projects. We expect to continue to make investments in and expand our product and service offerings to enhance our customers’ experience and satisfaction and to attract new customers. We will continue to capitalize and amortize R&D costs over 15 years for R&D performed outside of the U.S.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.